To include your compound in the COVID-19 Resource Center, submit it here.

Cancer

INDICATION: Esophageal cancer; cancer

Cell culture and mouse studies suggest SLC7A11 inhibitors could help treat p53-mutant esophageal cancer and other cancers that are resistant to p53 activators. In 10 p53-mutant esophageal cancer

Read the full 314 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE